No Data
No Data
RFK Jr. Could Prove a Surprise Boon for Stem-cell Stocks With Pivotal Year Ahead
Stem Cells Poised for Success in 2025 as Regulatory Environment Looks More Favorable -- Market Talk
If You'd Invested $5,000 in This ASX 300 Healthcare Stock a Year Ago, You'd Now Have $30,000!
Why 29Metals, Guzman Y Gomez, Mesoblast, and Pilbara Minerals Shares Are Falling Today
Mesoblast Secures Regenerative Advanced Therapy Designation From US FDA for Cellular Therapy Product; Shares Hit Near 3.5-Year High
What on Earth Is Happening With Mesoblast Shares Today?
101674396 : No one knows. Drop here deeply even approval also!!!
103424489 : I was expecting it to fly high but it came to my surprise, fell instead
No risk no Lambo 103424489 : pre-auction already fly high, the drop is due to super huge profit taking. im expecting it to go back up after it stabilises